• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GROSHONG PICC; PERIPHERALLY INSERTED CENTRAL CATHETER (PICC)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GROSHONG PICC; PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) Back to Search Results
Catalog Number 7717405
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 01/31/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.The device has not been returned to the manufacturer for evaluation.
 
Event or Problem Description
It was reported that on (b)(6) 2026, the patient underwent placement of a peripherally inserted central line (picc) catheter kit and associated catheters.On (b)(6) the patient reported pain in the arm on the side of the catheter.A comprehensive colour doppler ultrasound of the deep veins of the left upper limb revealed ¿post-picc thrombosis and inflammatory changes in the left axillary and brachial veins¿.In accordance with medical advice, the patient was treated with subcutaneous injections of low-molecular-weight heparin calcium combined with oral rivaroxaban for anticoagulation, and the swelling in the patient¿s arm gradually subsided.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GROSHONG PICC
Common Device Name
PERIPHERALLY INSERTED CENTRAL CATHETER (PICC)
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
veronica lee
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key24779454
Report Number3006260740-2026-02252
Device Sequence Number9935387
Product Code LJS
UDI-Device Identifier00801741035326
UDI-Public(01)00801741035326(11)250330(17)271130(10)REJZ1401
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K871998
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/20/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number7717405
Device Lot NumberREJZ1401
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/19/2026
Initial Report FDA Received Date04/03/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/30/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-